Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide <span style="font-variant: small-caps">d</span>-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide <span style="font-variant: small-caps">d</span>-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice

Mimetic peptides are potential therapeutic agents for atherosclerosis. <span style="font-variant: small-caps;">d</span>-[113–122]apolipoprotein (apo) J (<span style="font-variant: small-caps;">d</span>-[113–122]apoJ) is a 10-residue peptide that is predict...

Full description

Bibliographic Details
Main Authors: Andrea Rivas-Urbina, Anna Rull, Joile Aldana-Ramos, David Santos, Nuria Puig, Nuria Farre-Cabrerizo, Sonia Benitez, Antonio Perez, David de Gonzalo-Calvo, Joan Carles Escola-Gil, Josep Julve, Jordi Ordoñez-Llanos, Jose Luis Sanchez-Quesada
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Biomolecules
Subjects:
mimetic peptide
atherosclerosis
lipoprotein function
apolipoprotein J
LDL
HDL
Online Access:https://www.mdpi.com/2218-273X/10/6/829

Internet

https://www.mdpi.com/2218-273X/10/6/829

Similar Items